Question

Difficulty: HardDiagnostic Workup and Test Sequencing

An executive in her late twenties visits the ambulatory care clinic reporting six months of progressively worsening shortness of breath with physical exertion. She denies chronic cough, orthopnea, daytime fatigue, or prior lung disease. She has no significant medical history and takes only oral contraceptives. Vital signs are within normal limits, with an oxygen saturation of 96%96\% on ambient air. Physical examination reveals a prominent pulmonic component of the second heart sound and a faint parasternal heave. The lung fields are clear to auscultation, and there is no peripheral edema. Electrocardiography reveals right axis deviation and an incomplete right bundle branch block. A chest radiograph demonstrates prominent central pulmonary arteries without parenchymal infiltrates. Echocardiography shows a structurally normal left ventricle with an ejection fraction of 65%65\%, normal valvular function, and right ventricular enlargement with an estimated right ventricular systolic pressure of 5252 mmHg. Pulmonary function testing demonstrates a normal forced vital capacity, normal FEV1/FVC ratio, and a slightly reduced diffusion capacity for carbon monoxide (DLCO). Which of the following is the most appropriate next step in evaluating this patient's condition?

  1. Ventilation-perfusion (V/Q) scanAnswer
  2. B
    Right heart catheterization
  3. C
    Computed tomography pulmonary angiography
  4. D
    High-resolution computed tomography of the chest
  5. E
    Polysomnography

Answer

Ventilation-perfusion (V/Q) scan
The correct answer identifies the ventilation-perfusion (V/Q) scan as the next required diagnostic step. This patient has evidence of pulmonary hypertension (PH) on echocardiography. The diagnostic algorithm for PH requires a stepwise approach to classify the disease into one of the five World Health Organization (WHO) groups. The normal left ventricular function rules out Group 2 (left heart disease), and the normal forced vital capacity and clear chest radiograph make Group 3 (lung disease) highly unlikely. The next step is to evaluate for Group 4 (chronic thromboembolic pulmonary hypertension, or CTEPH). The V/Q scan is the screening modality of choice for CTEPH because it is highly sensitive for chronic, distal microvascular occlusions that may be missed by other modalities. Only after a V/Q scan is performed should the patient undergo right heart catheterization for definitive hemodynamic confirmation.

Step-by-Step Solution

1
Analyze the clinical presentation and initial workup.
The patient has signs of right heart strain and an echocardiogram demonstrating an elevated right ventricular systolic pressure without left-sided heart disease or significant pulmonary parenchymal disease.
This establishes a preliminary diagnosis of pulmonary hypertension (PH) and rules out World Health Organization (WHO) Group 2 (left heart disease) and Group 3 (lung disease/hypoxia) etiologies.
2
Determine the necessary diagnostic sequence for the remaining PH etiologies.
The algorithm dictates that once Groups 2 and 3 are ruled out, the patient must be evaluated for Group 4 (chronic thromboembolic pulmonary hypertension, or CTEPH).
CTEPH is a potentially curable form of pulmonary hypertension (via pulmonary endarterectomy) and must be excluded before diagnosing Group 1 (pulmonary arterial hypertension).
3
Select the most appropriate non-invasive modality to screen for CTEPH.
Ventilation-perfusion (V/Q) scanning is the imaging modality of choice.
A V/Q scan is significantly more sensitive than computed tomography pulmonary angiography (CTPA) for detecting chronic, organized thromboembolic disease.

Key Concept

In the workup of unexplained pulmonary hypertension, after echocardiography rules out left heart disease and pulmonary function tests rule out lung disease, a ventilation-perfusion (V/Q) scan is the required next step to screen for chronic thromboembolic pulmonary hypertension (CTEPH) prior to right heart catheterization.
Rate this question